Sinopharm subsidiary reports mixed half-year results

China National Medical Device Co, a subsidiary of Sinopharm Group, reported revenue declined 1.48% to RMB 36.36bn for the six months ended June 30, 2025. Operating profit fell 8.28% to RMB 684m.

However, net cash flow from operations improved dramatically, with outflows reducing 67.88% from RMB 7.73bn to RMB 2.48bn year-on-year. Total assets grew 3.94% to RMB 64.09bn.